31.50Open31.50Pre Close0 Volume1 Open Interest60.00Strike Price0.00Turnover115.13%IV-11.79%PremiumDec 20, 2024Expiry Date43.73Intrinsic Value100Multiplier22DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9817Delta0.0015Gamma2.35Leverage Ratio-0.0359Theta0.0347Rho2.31Eff Leverage0.0114Vega
Champion Homes Stock Discussion
$Champion Homes (SKY.US)$ $Cavco Industries (CVCO.US)$ $Berkshire Hathaway-B (BRK.B.US)$
• $Allegiance (ABTX.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $43
• $Bunge (BG.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $106 (from $130)
• $Cerence (CRNC.US)$ : RBC Capital Upgrades to Sector Perform from Underperform - PT $27 (from $28)
• $First Mid Bancshares (FMBH.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $45
• $Lamar Advertising Co (LAMR.US)$ : Citigroup Up...
• $SpringWorks Therapeutics (SWTX.US)$ +19.2% (Nirogacestat Achieved Primary and All Key Secondary Endpoints in Phase3DeFi Trial )
• $Roivant Sciences (ROIV.US)$ +7.1% (FDA has approved VTAMA (tapinarof) cream)
• $Ocugen (OCGN.US)$ +5.9% (announces that it is diversifying its innovative pipeline by introducing a Phase 3 cell therapy platform technology called Ne?Cart)
• $Champion Homes (SKY.US)$ +4.4% (In reaction to earnings)
• $NetEase (NTES.US)$ +4.1% (In...
No comment yet